Nanobiotix Operating Expenses Growth & History (NANO)
Nanobiotix's operating expenses was €43.4M for fiscal 2025.
View full Nanobiotix company overviewNanobiotix annual operating expenses history
2018
2019
2020
2021
2022
2023
2024
2025
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €43.4M | −€17.8M | −29.07% |
| 2024 | 2024-12-31 | €61.2M | −€1.8M | −2.83% |
| 2023 | 2023-12-31 | €63.0M | €11.5M | +22.36% |
| 2022 | 2022-12-31 | €51.5M | −€3.7M | −6.79% |
| 2021 | 2021-12-31 | €55.2M | €16.3M | +41.82% |
| 2020 | 2020-12-31 | €38.9M | −€10.4M | −21.04% |
| 2019 | 2019-12-31 | €49.3M | €15.8M | +47.02% |
| 2018 | 2018-12-31 | €33.5M | — | — |
Nanobiotix operating expenses trends
Over the last five fiscal years, Nanobiotix's operating expenses increased from €38.9M to €43.4M, a change of €4.5M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nanobiotix source filings ↗